Related Experiment Video
Updated: Jul 18, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Diabetes mellitus and dementia.
F Pasquier1, A Boulogne, D Leys
1Department of Neurology, EA 2691, Memory Clinic, Lille, France. pasquier@chru-lille.fr
Diabetes & Metabolism
|November 18, 2006
Summary
Diabetes mellitus (DM) is linked to cognitive decline, increasing the risk of Alzheimer's disease (AD) and vascular dementia. Interventions to mitigate this cognitive decline in diabetic patients are underutilized.
Area of Science:
- Neurology
- Endocrinology
- Geriatrics
Background:
- Alzheimer's disease (AD) and diabetes mellitus (DM) are prevalent in the elderly, sharing significant impacts on quality of life and healthcare costs.
- Type 2 DM is associated with moderate cognitive impairment, affecting memory and executive functions, and elevates the risk of vascular dementia and AD.
Purpose of the Study:
- To review epidemiological evidence on the association between type 2 DM and cognitive impairment, including AD and vascular dementia.
- To explore the mechanisms linking DM to cognitive decline and AD pathogenesis.
- To highlight the underutilization of interventions that could reduce cognitive decline in diabetic patients.
Main Methods:
- Systematic review of epidemiological studies on cognitive impairment in patients with DM.
- Analysis of potential pathophysiological links between DM, cerebrovascular disease, and AD.
- Examination of factors interacting with DM in dementia risk.
Main Results:
- Type 2 DM is independently associated with moderate cognitive impairment and increased risk of vascular dementia and AD.
- DM contributes to dementia risk via atherogenic factors, stroke, and impaired vascular reactivity due to advanced glycosylation end products.
- Mechanisms include exacerbation of beta-amyloid neurotoxicity, altered insulin function, and reduced brain glucose transport.
Conclusions:
- DM is a significant risk factor for cognitive decline and dementia, including AD.
- Cerebrovascular disease and DM share pathological pathways that exacerbate AD.
- Effective interventions to reduce cognitive decline in DM patients are not adequately implemented.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...